Hypogonadism
📧 Sign up to get email alerts when something new happens for Hypogonadism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors [Phase 2]
A Phase 2 clinical trial evaluated the efficacy and safety of fispemifene in hypogonadal men with erectile dysfunction unresponsive to PDE5 …
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men [Phase 1]
A Phase 1 trial assessing the steady-state feedback effects of testosterone on luteinizing hormone secretion in young and older men, outlini…
-
FDA approval · 2010-01-19FDA Approved: ESTRADIOL VALERATE — Original Application (American Regent, Inc.)
FDA approved Estradiol Valerate under an Original Application (ANDA 090920), granting a new generic product status to American Regent, Inc.
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure [Phase 1]
Phase 1 study evaluating serum testosterone levels in non-dosed females after secondary exposure; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-22Clinical Trial Update: Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism [NA]
This clinical trial update reports on testosterone’s effects on lipolysis, insulin sensitivity, and protein metabolism in hypogonadism; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion [Phase 1]
Phase 1 study assessing how deodorant, antiperspirant, and washing affect the pharmacokinetics of 2% testosterone MD Lotion in individuals w…
-
CLINICAL_TRIALS trial_result · 2009-09-21Clinical Trial Update: Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men [Phase 4]
Phase 4 clinical trial update examining the effects of Testim (testosterone gel) plus training in hypogonadal men; current status is unknown…
-
FDA approval · 2009-09-18FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)
FDA approved a supplemental application for AndroGel (testosterone) from ASCEND Therapeutics U.S., LLC.
-
FDA label_change · 2009-03-19FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)
FDA approved a supplemental application for AndroGel (testosterone) by ASCEND Therapeutics U.S., LLC to update the product labeling.
-
FDA approval · 2009-01-06FDA Approved: TESTOSTERONE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for TESTOSTERONE from Strides Pharma Science Limited. The approval relates to testosterone replaceme…
-
CLINICAL_TRIALS trial_result · 2008-10-01Clinical Trial Update: The Effect of Testosterone on Mood and Quality of Life [NA]
A completed clinical trial assessed the effect of testosterone on mood and quality of life in individuals with gonadal disorders, depressive…
-
CLINICAL_TRIALS trial_result · 2008-09-19Clinical Trial Update: The Effects of Testosterone on Prostate Tissue (ACYP-1) [Phase 1]
Phase 1 trial ACYP-1 assessing the effects of testosterone on prostate tissue has been completed. The study, sponsored by the University of …
-
CLINICAL_TRIALS trial_result · 2008-09-19Clinical Trial Update: Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone [Phase 2]
Phase 2 study evaluating the pharmacokinetics of oral testosterone in men for hypogonadism and contraception indications; the trial is compl…
-
CLINICAL_TRIALS trial_result · 2008-08-25Clinical Trial Update: Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone [Phase 3]
Phase 3 trial evaluating co-administration of testosterone with PDE5 inhibitors in erectile dysfunction patients who do not respond to PDE5 …
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males [Phase 2]
A Phase 2 pharmacokinetic study evaluating a testosterone topical lotion in men with hypogonadism has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men [Phase 3]
A Phase 3 clinical trial update examining the effects of intramuscular testosterone undecanoate on biochemical and anthropometric measures i…
-
FDA approval · 2008-06-10FDA Approved: NOVAREL — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for NOVAREL (gonadotropin, chorionic) filed by Ferring Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2008-04-18Clinical Trial Update: Open-Label Study of ARD-0403 in Testosterone Deficient Men [Phase 3]
An open-label Phase 3 trial of ARD-0403 in testosterone-deficient men has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Open-Label Study of ARD-0403 in Testosterone Deficient Men [Phase 3]
An open-label Phase 3 trial of ARD-0403 in men with testosterone deficiency (hypogonadism) has been terminated.
-
CLINICAL_TRIALS research · 2008-03-11Clinical Trial Update: Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury. [NA]
Clinical trial update reporting completion of provocative testing on the pituitary-gonadal axis in people with spinal cord injury.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement
This clinical trial update examines the effects on brain function in individuals with Lupron-induced hypogonadotropic hypogonadism, comparin…
-
CLINICAL_TRIALS trial_result · 2008-03-03Clinical Trial Update: A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism [Phase 2]
A Phase 2 clinical trial evaluating Fispemifene for hypogonadism has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-17Clinical Trial Update: Study of 3 Doses of ARD-0403 in Testosterone Deficient Men [Phase 2]
A Phase 2 clinical trial evaluating three doses of ARD-0403 in testosterone-deficient men has completed. The study investigated ARD-0403 for…
-
FDA approval · 2007-12-27FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)
FDA approved a supplemental application for ANDROGEL (testosterone) filed by ASCEND Therapeutics U.S., LLC.
-
FDA approval · 2007-12-13FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)
FDA approved a supplemental application for AndroGel (testosterone) from ASCEND Therapeutics U.S., LLC.